MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
OPKO Health Shares 2011-2026 | OPK
Annual Shares OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 694 M | 752 M | 719 M | 648 M | 641 M | 595 M | 567 M | 559 M | 502 M | 500 M | 419 M | 355 M | 296 M | 281 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 752 M | 281 M | 538 M |
Quarterly Shares OPKO Health
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 788 M | 672 M | 695 M | 697 M | 707 M | 752 M | 752 M | 752 M | - | 750 M | 713 M | 660 M | - | 652 M | 647 M | 641 M | - | 641 M | 641 M | 641 M | - | 586 M | 586 M | 586 M | - | 560 M | 560 M | 559 M | - | 559 M | 559 M | 558 M | - | 552 M | 548 M | 546 M | - | 501 M | 462 M | 446 M | - | 428 M | 413 M | 413 M | - | 361 M | 337 M | 313 M | 298 M | 298 M | - | - | 298 M | - | 288 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 788 M | 288 M | 557 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Biodesix
BDSX
|
130 M | $ 15.54 | 5.79 % | $ 2.02 B |  USA |
 |
Biomerica
BMRA
|
2.3 M | $ 2.16 | 1.41 % | $ 4.96 M | USA |
 |
Bioventus
BVS
|
66.6 M | $ 9.15 | 1.67 % | $ 610 M | USA |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 16.34 | 0.06 % | $ 494 M | USA |
 |
Guardant Health
GH
|
125 M | $ 83.59 | -1.54 % | $ 10.5 B | USA |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M |  Israel |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 101.28 | 0.93 % | $ 8.35 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
80.4 M | $ 570.21 | -1.43 % | $ 45.9 B | USA |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
117 M | - | -6.19 % | $ 10.5 M | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 74.24 | -1.97 % | $ 5.01 B | USA |
 |
Co-Diagnostics
CODX
|
29.3 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 460.74 | 0.83 % | $ 13.3 B | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M |  China |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
Mettler-Toledo International
MTD
|
20.6 M | $ 1 264.46 | 1.94 % | $ 26.1 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 4.61 | -1.07 % | $ 427 M | USA |
 |
National Research Corporation
NRC
|
22.4 M | $ 17.44 | -0.4 % | $ 390 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Natera
NTRA
|
98.4 M | $ 194.52 | -2.78 % | $ 19.1 B | USA |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 159.19 | 0.75 % | $ 7.89 B | USA |
 |
IQVIA Holdings
IQV
|
172 M | $ 166.09 | -0.52 % | $ 28.6 B | USA |
 |
Organovo Holdings
ONVO
|
1.46 M | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
4.66 M | - | -16.95 % | $ 1.54 M | USA |
 |
Pacific Biosciences of California
PACB
|
300 M | $ 1.39 | - | $ 417 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
5.44 M | $ 1.18 | -19.18 % | $ 6.43 M | USA |
 |
Interpace Biosciences
IDXG
|
4.39 M | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
159 M | $ 125.98 | 1.77 % | $ 20 B | USA |
 |
Personalis
PSNL
|
59.3 M | $ 7.78 | 2.23 % | $ 461 M | USA |
 |
QIAGEN N.V.
QGEN
|
223 M | - | - | $ 10.6 B |  Niderland |
 |
Precipio
PRPO
|
1.3 M | $ 26.6 | -1.23 % | $ 34.5 M | USA |
 |
RadNet
RDNT
|
75.2 M | $ 59.87 | -3.03 % | $ 4.5 B | USA |
 |
Celcuity
CELC
|
39.4 M | $ 102.01 | -4.44 % | $ 4.02 B | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 266.12 | 0.64 % | $ 22.1 B | USA |
 |
ENDRA Life Sciences
NDRA
|
537 K | $ 3.46 | -0.57 % | $ 1.86 M | USA |
 |
NeoGenomics
NEO
|
128 M | $ 7.86 | -2.96 % | $ 1.01 B | USA |
 |
Renalytix AI plc
RNLX
|
108 M | - | 5.66 % | $ 22.7 M | Britain |